US4144327A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Antimicrobial composition comprising lytic enzymes from physarum and an antimycotic agent
Assignee: GD Searle LLC
•
Filing: 1978-03-20
•
Granted: 1979-03-13
•
Expires: 1998-03-20
Abstract
Abstract The present invention encompasses an antimicrobial composition comprising an extract of lytic enzymes from Physarum. These lytic enzymes are particularly effective antimycotic agents when used in conjunction with conventional antimycotic agents.
Inventors
- 👤 David A. L. Davies
- 👤 Anthony M. S. Pope
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-27 22:03
CPC Classifications
C; C12; C12N; C12N9/00; C12N9/14; C12N9/24; C12N9/2402; C12N9/2462; C12Y; C12Y302/00; C12Y302/01; C12Y302/01017; A; A61; A61K; A61K38/00; Y; Y10; Y10S; Y10S435/00; Y10S435/8215; Y10S435/911
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
27 words
A method for treating fungal infections in animals comprising administering to an animal in need of antifungal treatment an effective amount of mycolytic enzymes extracted from Physarum.
Claim 2
Independent Claim
27 words
A method for treating fungal infections in animals comprising administering to an animal in need of antifungal treatment an effective amount of mycolytic enzymes extracted from Physarum.
Claim 3
Independent Claim
33 words
A method for treating fungal infections in animals comprising administering to an animal in need of anti-fungal treatment an effective amount of mycolytic enzymes extracts from Physarum in conjunction with an antimycotic agent.
Claim 4
Independent Claim
33 words
A method for treating fungal infections in animals comprising administering to an animal in need of anti-fungal treatment an effective amount of mycolytic enzymes extracts from Physarum in conjunction with an antimycotic agent.
Claim 5
Dependent Claim
37 words
A method according to claim 2 for treating fungal infections in animals comprising administering to an animal in need of anti-fungal treatment an effective amount of mycolytic enzymes extracted from Physarum in conjunction with Amphotericin-B or Nystatin.
Claim 6
Dependent Claim
37 words
A pharmaceutical composition suitable for combining with a pharmaceutically acceptable carrier comprising an effective amount of a sterile pyrogen free, lyophilised extract of lytic enzymes from Physarum in combination with an effective amount of an antimycotic agent.
Claim 7
Dependent Claim
37 words
A pharmaceutical composition suitable for combining with a pharmaceutically acceptable carrier comprising an effective amount of a sterile pyrogen free, lyophilised extract of lytic enzymes from Physarum in combination with an effective amount of an antimycotic agent.
Claim 8
Dependent Claim
16 words
A pharmaceutical composition, according to claim 4, wherein the antimycotic agent is Amphotericin-B, Nystatin, or 5-fluorocystosine.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1982-03-12 | 1982-09-11 | 1983-03-13 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1986-03-12 | 1986-09-11 | 1987-03-13 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1990-03-12 | 1990-09-11 | 1991-03-13 | $7700.00 | Window Closed / Lapsed |